Newsroom
The latest version of RT Elements is now ready for roll-out in the US
Following CE approval in May 2023 and the first installations in Europe, the newest version of Brainlab RT Elements is now FDA cleared and can be rolled out in the US.
This release includes the new Elements Retreatment Review, a unique application that provides a comprehensive overview of previous treatments, as well as new lesions, supporting clinicians in the management of recurrent multiple metastases.
Please contact your sales representative to learn more.